Bayer CEO Baumann faces revolt from investor Temasek Holdings: reportnews2022-03-28T15:27:22+00:00March 28th, 2022|Fierce Pharma|
Pfizer and BioNTech go to Hollywood with splashy Oscars sponsorshipnews2022-03-28T14:51:32+00:00March 28th, 2022|Fierce Pharma|
‘In the long-term interests:’ FDA oncology chief defends rejection of Lilly, Innovent cancer drugnews2022-03-28T14:36:50+00:00March 28th, 2022|Fierce Pharma|
FDA halts use of GlaxoSmithKline and Vir’s COVID-19 drug Xevudy in 8 northeast statesnews2022-03-28T13:19:31+00:00March 28th, 2022|Fierce Pharma|
UCB wins wider Fintepla label, setting up showdown with Jazz’s Epidiolexnews2022-03-28T12:49:37+00:00March 28th, 2022|Fierce Pharma|
Sanofi rare disease med clinches world-first nod in Japan, presaging potential approvals in US, Europenews2022-03-28T12:46:53+00:00March 28th, 2022|Fierce Pharma|
Ten23 health expands former swissfillon facility in Visp, Switzerlandnews2022-03-28T12:41:00+00:00March 28th, 2022|Fierce Pharma|
AAD 2022: Incyte’s latest Opzelura data show med’s benefit grows over time in vitiligonews2022-03-26T12:37:27+00:00March 26th, 2022|Fierce Pharma|
HHS is investigating how consumers are marketed accelerated approval drugsnews2022-03-25T16:23:31+00:00March 25th, 2022|Fierce Pharma|
Household-name Moderna rolls out a self-aware campaign for Spikevax vaccinenews2022-03-25T15:04:28+00:00March 25th, 2022|Fierce Pharma|
